Cargando…
Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment
AIM: 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) is valuable in the management of patients with oesophageal cancer, but a role in gastric cancer staging is debated. Our aim was to review the role of FDG PET-CT in a large gastric cancer cohort in a tertiary UK...
Autores principales: | Bosch, Karen D., Chicklore, Sugama, Cook, Gary J., Davies, Andrew R., Kelly, Mark, Gossage, James A., Baker, Cara R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075833/ https://www.ncbi.nlm.nih.gov/pubmed/31377821 http://dx.doi.org/10.1007/s00259-019-04429-x |
Ejemplares similares
-
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
por: Moore, Jonathan L., et al.
Publicado: (2023) -
Optimisation of CT protocols in PET-CT across different scanner models using different automatic exposure control methods and iterative reconstruction algorithms
por: Gould, Sarah-May, et al.
Publicado: (2021) -
Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT
por: O’Shea, Robert J., et al.
Publicado: (2022) -
FDG PET-CT: Need for Vigilance in Patients Treated with Bleomycin
por: Paschali, Anna N, et al.
Publicado: (2017) -
FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023)